ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)

ClinicalTrials.gov ID: NCT00018902

Public ClinicalTrials.gov record NCT00018902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 3:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Treatment of SSRI-Resistant Depression in Adolescents (TORDIA)

Study identification

NCT ID
NCT00018902
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
University of Pittsburgh
Other
Enrollment
334 participants

Conditions and interventions

Conditions

Interventions

  • Citalopram Drug
  • Cognitive Behavioral Therapy (CBT) Behavioral
  • Fluoxetine Drug
  • Venlafaxine Drug

Drug · Behavioral

Eligibility (public fields only)

Age range
12 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2000
Primary completion
Feb 28, 2007
Completion
Feb 28, 2007
Last update posted
Mar 11, 2014

2001 – 2007

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
University of California at Los Angeles Los Angeles California 90095-6967
Kaiser Permanente Center for Health Research Portland Oregon 97227-1098
Western Psychiatric Institute and Clinic of University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Brown University Providence Rhode Island 02906
University of Texas - Southwestern Medical Center Dallas Texas 75390-8589
University of Texas Medical Branch Galveston Texas 77555-0188

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00018902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2014 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00018902 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →